Unknown

Dataset Information

0

Divergent Primary Immune Responses Induced by Human Immunodeficiency Virus-1 gp120 and Hepatitis B Surface Antigen Determine Antibody Recall Responses.


ABSTRACT: The development of a vaccine based on human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) that elicits potent protective antibodies against infection has been challenging. Recently, we compared the antibody production patterns of HIV-1 Env gp120 and hepatitis B virus surface antigen (HBsAg) to provide insights into how we may improve the protective efficacy of Env-based immunogens. Our previous study showed that HIV Env and HBsAg display different mechanisms of antibody elicitation and that T cells facilitate the responses to repeated immunizations. Here, to elucidate the detailed roles of primary immunization in immune memory response formation and antibody production, we immunized C57BL/6 mice with each antigen and evaluated the development of T follicular helper (Tfh) cells, germinal centers, and the memory responses involved in prime and boost immunizations. We found that after prime immunization, compared with HBsAg, gp120 induced higher frequencies of Tfh cells and programmed death (PD)-1+ T cells, greater major histocompatibility complex II expression on B cells, comparable activated B cells, but weaker germinal center (GC) reactions and memory B cell responses in the draining lymph nodes, accompanied by slower antibody recall responses and poor immune memory responses. The above results suggested that more PD-1+ T cells arising in primary immunization may serve as major contributors to the slow antibody recall response elicited by HIV-1 Env.

SUBMITTER: Yuan L 

PROVIDER: S-EPMC6335216 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Divergent Primary Immune Responses Induced by Human Immunodeficiency Virus-1 gp120 and Hepatitis B Surface Antigen Determine Antibody Recall Responses.

Yuan Li L   Chen Wen-Jiang WJ   Wang Jia-Ye JY   Li Yan Y   Tian Dan D   Wang Ming-Xia MX   Yu Hao-Tong HT   Xu Ying-Chu YC   Li Di D   Zhuang Min M   Ling Hong H  

Virologica Sinica 20181219 6


The development of a vaccine based on human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) that elicits potent protective antibodies against infection has been challenging. Recently, we compared the antibody production patterns of HIV-1 Env gp120 and hepatitis B virus surface antigen (HBsAg) to provide insights into how we may improve the protective efficacy of Env-based immunogens. Our previous study showed that HIV Env and HBsAg display different mechanisms of antibody elici  ...[more]

Similar Datasets

| S-EPMC48828 | biostudies-other
| S-EPMC3465803 | biostudies-literature
| S-EPMC161940 | biostudies-literature
| S-EPMC10395872 | biostudies-literature
| S-EPMC4414269 | biostudies-literature
| S-EPMC7922731 | biostudies-literature
| S-EPMC7373618 | biostudies-literature
| S-EPMC6056386 | biostudies-literature
| S-EPMC10383918 | biostudies-literature
| S-EPMC8140094 | biostudies-literature